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Received July 24, 2013; accepted March 11, 2014AbstractBackground: Predicting functional improvement at an early stage after stroke is critical to setting treatment goals and strategies. The aim of this
study was to identify factors that can predict motor function improvement at 3 months and 6 months poststroke.
Methods: Forty-four patients with stroke were included in the study. We recorded age, interval between stroke onset and initiation of physical
therapy, stroke type, history of diabetes or cardiovascular disease, functional status prior to stroke, cognition, motivation, walking ability, eating
ability, hemineglect, sensory function, and brain lesion site as predictive factors. The Stroke Rehabilitation Assessment of Movement, Berg
Balance Scale, Timed Up & Go Test, and the 6-Minute Walk Test were conducted upon intake and at 3 months and 6 months poststroke. Patients
were assigned to a progressive group or a nonprogressive group based on their improvement in four functional measures. Variables for which
there were significant group differences were used for stepwise discriminant analysis as determining factors and for setting the prediction model.
Results: Patient age, history of diabetes, functional status prior to stroke, and motivation were predictive factors of functional progress at 3
months poststroke. Motivation and functional status prior to stroke predicted functional progress at 6 months poststroke. By comparing the
discriminant function values of the progressive and nonprogressive groups, functional improvement can be predicted.
Conclusion: Functional status prior to stroke and motivation are predictive of functional outcome at 3 months and 6 months poststroke. We have
provided a formula that can be used to predict a patient’s progress and then set treatment goals and programs accordingly.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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1e8 1,5,7e9 1,3,5,8 1,3,5,7,91. Introduction
Cerebrovascular disease often leads to persistent disability
in daily living activities. Patients and their families typically
express concern about the potential for improvement of motor
function. If the potential for improvement could be predicted
early, strategies for best managing motor impairment could be
developed, allowing for more cost effective care and benefiting
patients and their families.Conflicts of interest: The authors declare that there are no conflicts of interest
related to the subject matter or materials discussed in this article.
* Corresponding author. Dr. Ray-Yau Wang, Department of Physical Ther-
apy and Assistive Technology, National Yang-Ming University, 155, Section 2,
Li Nong Street, Taipei 112, Taiwan, ROC.
E-mail address: rywang@ym.edu.tw (R.-Y. Wang).
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1726-4901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical AssAge, sex, brain lesion site, stroke type,
cognitive function,7,8,10 functional status at admission,4e7,11,12
stroke duration,3,5,7 comorbidity,7e9 hemineglect,1,3,7 and
aphasia1,3,7 have all been considered as possible predictors of
functional improvement in stroke patients. Regarding age,
some studies suggest that it is not an important factor affecting
functional progress1,2,5e8 whereas others indicate that it is a
significant predictor of functional improvement.3,4 Sex,1,5,7e9
brain lesion site,1,3,5,8 stroke type,1,3,5,7,9 and comorbidity7e9
have consistently been found not to be important de-
terminants of functional progress. Functional status at admis-
sion is a consistent, significant predictor of functional
improvement.4e7,11,12 However, conflicting findings have been
reported for cognitive function,7,8,10 stroke duration,3,5,7
hemineglect,1,3,7 and aphasia.1,3,7ociation. All rights reserved.
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improvement in stroke patients are cross-sectional and mea-
sure functional outcomes only at the time of hospital
discharge. This does not capture the real potential for
improvement because a patient’s recovery might last for 6
months or longer. In addition, most studies use the Functional
Independence Measure (FIM) as a measurement tool. The FIM
is reliable, valid, sensitive, and universal, but it can be prob-
lematic because ceiling effects in patients with mild disability
can impede documentation of progress.
In the present studywe sought to identify factors predictive of
motor function improvement in stroke patients over an extended
observational timeline spanning 6 months poststroke. We used
four different functional measurement tools [Stroke Rehabili-
tation Assessment of Movement (STREAM), Berg Balance
Scale (BBS), Timed Up & Go Test (TUG), and 6-Minute Walk
Test (6MWT)] to avoid possible ceiling or floor effects, and we
defined improvement in terms of clinical significance to docu-
ment meaningful improvement. Our goal was to develop a
prediction model for 3 months and 6 months poststroke.
2. Methods2.1. PatientsStroke patients were recruited from a university hospital in
Taiwan. The inclusion criteria were: (1) hospitalized for
stroke, which was diagnosed by computed tomography or
magnetic resonance imaging; and (2) able to follow verbal
commands or instructions. The exclusion criteria were: (1)
recurrent stroke; (2) hospitalized for other diseases or reha-
bilitation; and (3) not able to complete the experimental pro-
cedures for any reason. A total of 53 patients out of 90 patients
recruited met the inclusion criteria, gave informed consent,
and participated in the study. This study was reviewed and
approved by the Institutional Review Board of the National
Yang-Ming University, Taipei, Taiwan.2.2. Outcome measurementsSTREAM is used to evaluate recovery of voluntary
movement and basic mobility following stroke. It consists of
30 items divided into three subscales (upper limb movements,
lower limb movements, and basic mobility) with a total score
of 70 points.13 STREAM has good inter- and intrarater reli-
ability (correlation coefficients  0.96) and good internal
consistency (Cronbach a  0.98).14 Its correlation coefficients
with the FugleMeyer Assessment scale and Barthel Index
scale are 0.95 and 0.67, respectively, indicating good con-
current and convergent validity.15 The smallest significant
difference for the STREAM is 5.5413; therefore, a six-point
increase from pretest to posttest is considered to be clini-
cally significant improvement.
The BBS is the most widely used tool for assessing balance
clinically. It contains 14 items related to functions of daily
living, including dynamic and static balancing abilities as well
as the ability to change positions. The total score is 56 points,with 0e4 points for each item. This scale has good inter- and
intrarater reliability (correlation coefficient  0.97) and good
internal consistency for stroke patients (Cronbach a  0.97).16
With regard to its validity, it is highly correlated with motor
function and performance in stroke patients.17 The minimum
important difference in the BBS is suggested to be six points.18
The TUG is used to evaluate basic functional mobility.
Patients are seated in a chair, stand up, walk 3 m, turn around,
return to the chair, and sit down. The time needed to complete
these tasks is recorded. The TUG has good testeretest reli-
ability, with an intraclass correlation coefficient of 0.96.19
With regard to its validity, the coefficient of correlation with
the Barthel Index scale is 0.78.20 The 95% confidence in-
terval value of the smallest real difference for the TUG test
ranges between 3.75 seconds and 2.59 seconds19; thus, a
reduction of 4 seconds or more in the time to complete the
tasks is considered real progress.
The 6MWT is used to measure walking speed and endur-
ance. Patients are instructed to walk back and forth at a self-
selected pace along a 10-m walkway for 6 minutes and rests
are taken as needed. The total distance traveled is recorded.
The 6MWT has high testeretest reliability, with an intraclass
correlation coefficient of 0.99.19 The minimum important
difference in the 6MWT is 19e22 m21; therefore, an increase
of 22 m or more from a previous test is considered clinically
significant improvement.2.3. Experimental proceduresBasic data including sex, age, interval between stroke onset
and initiation of physical therapy, stroke type (hemorrhagic or
ischemic), history of diabetes, history of cardiovascular dis-
ease, functional status prior to stroke (independent or
disabled), cognitive function (normal or mild, moderate, or
severe dysfunction), motivation (good, ordinary, or poor),
eating ability (independent or dependent), walking ability
(independent or dependent), hemineglect, sensory function
(normal or impaired), and brain lesion site (cerebral cortex,
subcortical, or multiple) were collected from patients during
an initial assessment. Functional status prior to stroke was
classified as “independent” if the patient had been independent
in activities of daily living according to the patient or family,
and as “disabled” if the patient needed assistance with activ-
ities of daily living. Cognitive function was tested using a 10-
item Short Portable Mental Status Questionnaire, in which:
0e2 incorrect answers indicates “normal function”; 3e4
incorrect answers indicates “mild dysfunction”; 5e7 incorrect
answers indicates “moderate dysfunction”; and 8e10 incorrect
answers indicates “severe dysfunction”.22 Motivation was
classified as “good” if the patient actively engaged in activ-
ities; “ordinary” if the patient had to be urged to engage in
activities; and “poor” if the patient was unwilling to engage in
activities, according to the patient’s family. Eating ability was
classified as “independent” if the patient could feed himself or
herself independently, and as “dependent” if the patient
needed assistance. Walking ability was classified as “inde-
pendent” if the patient could ambulate independently with or
471Y.-H. Wang et al. / Journal of the Chinese Medical Association 77 (2014) 469e476without assistive devices, and as “dependent” if the patient
could ambulate only with assistance from others. Hemineglect
was tested using the Symbol Cancellation Test and was indi-
cated by asymmetrical symbol cancellation between two
sides.23 In terms of sensory function, proprioception
(including motion sense and position sense) of the hip, knee,
and ankle joints was assessed. Patients who responded
correctly for all three joints were classified as having “normal”
sensory function; otherwise, they were classified as
“impaired”.24 Brain lesion site was categorized based on
magnetic resonance imaging or computed tomography results.
All patients completed the STREAM and BBS assessments.
Patients who were able to walk independently were assessed
using the TUG Test. The 6MWT was used with patients who
were able to complete it. Patients were given an initial assess-
ment when first seen in the rehabilitation department and were
assessed again at 3 months and 6 months poststroke. If the dif-
ference in any of the four outcomes measures between the initial
assessment and 3-month poststroke assessment, or between the
initial assessment and 6-month poststroke assessment, met the
minimum important difference or smallest real difference as
described earlier, a true improvement in motor function was
determined. Based on these outcomes patients were assigned to
two groups: the progressive group, which showed true
improvement in at least one outcome measure, and the nonpro-
gressive group, which showed true improvement in none of the
outcome measures. We also recorded frequency of physical and
occupational therapy 3 months and 6 months poststroke.2.4. Data analysisThe data were analyzed using the SPSS version 12.0 (SPSS
Inc., Chicago, IL, USA).
We used independent samples t tests to compare age, in-
terval between stroke onset and initiation of physical therapy,
and frequency of physical and occupational therapy in the
progressive and nonprogressive groups. Chi-square tests were
used to compare nominal variables (sex, stroke type, history of
diabetes, history of cardiovascular disease, functional status
prior to stroke, cognitive function, motivation, eating ability,
walking ability, hemineglect, sensory function, and brain
lesion site) between the two groups. In cases in which the
expected numbers were below five in the cross-tables, Fisher’s
exact test was substituted for the Chi-square test. Statistical
significance was set at p < 0.05.
Variables for which there were significant group differences
were put into stepwise discriminant analysis to identify vari-
ables with discriminant ability. The discriminant function was
established as the prediction model to predict potential for
improvement of motor function at 3 months and 6 months
poststroke.
3. Results
Fifty-three stroke patients were enrolled in this study. Of
these, 44 completed the second and third assessments, and nine
were dropped from the study because they declined to continue(n ¼ 4), moved to another city (n ¼ 2), experienced problems
with traveling (n¼ 1), became ill (n¼ 1), or died (n¼ 1; Fig. 1).
The mean age of the 44 participants (24 men and 20 women)
was 68.7 years (range, 33e88 years). The mean duration from
stroke onset to initiation of physical therapy was 10.4 days
(range, 2e34 days). Ten participants had suffered ischemic
stroke, and 34 suffered hemorrhagic stroke. Thirty-seven par-
ticipants had a subcortical lesion, four had a cortical lesion, and
three had multiple lesions. Table 1 presents the demographic
and basic information of the participants. The results of the four
outcome measurements are presented in Table 2.3.1. Initial assessment to 3-month poststroke assessmentThirty-five patients (79.5%) were assigned to the progres-
sive group and nine (20.5%) were assigned to the nonpro-
gressive group. The groups differed significantly in age
( p ¼ 0.011), history of diabetes ( p ¼ 0.021), history of car-
diovascular disease ( p ¼ 0.041), functional status prior to
stroke ( p ¼ 0.038), cognitive function ( p ¼ 0.044), motivation
( p ¼ 0.003), eating ability ( p ¼ 0.003), and sensory function
( p ¼ 0.018; Table 1).
The eight variables with significant group differences were
put into the stepwise discriminant analysis. Motivation, func-
tional status prior to stroke, history of diabetes, and age were
selected based on the results of the stepwise discriminant
analysis. In the progressive group, Fisher’s linear discriminant
function coefficient for age was 0.483, for history of diabetes
was 4.884, for functional status prior to stroke was 32.065, and
for motivation was 2.698. The constant was 34.740. The
derived linear discriminant function in the progressive group
was Yprogress, 3m ¼ 34.740 þ 0.483  age þ 4.884  history
of diabetes þ 32.065  functional status prior to
stroke þ 2.698  motivation. Y indicates the discriminant
value. In the nonprogressive group, Fisher’s linear discrimi-
nant function coefficient for age was 0.576, for history of
diabetes was 7.595, for functional status prior to stroke was
39.904, and for motivation was 4.837. The constant was
56.661. The derived linear discriminant function in the
nonprogressive group was Ynonprogress, 3m ¼ 56.661 þ 0.576
 age þ 7.595  history of diabetes þ 39.904  functional
status prior to stroke þ 4.837  motivation (Table 3). When
all observation values were reclassified and verified by this
derived linear discriminant function, 38 of 44 participants
were predicted correctly. The correct distinction rate was
86.4% (Table 4).3.2. Initial assessment to 6-month poststroke assessmentOnly one of nine patients in the nonprogressive group at
3 months showed clinically significant progress at 6 months,
and thus was assigned to the progressive group 6 months
poststroke. Therefore, a total of 36 patients (81.8%) were
assigned to the progressive group and eight patients (18.2%)
were assigned to the nonprogressive group. There were
significant differences in age ( p ¼ 0.013), history of dia-
betes (p ¼ 0.048), functional status prior to stroke
Before starting 
the first physical 
therapy treatment 
3 months poststroke 
6 months poststroke 
Initial assessment 
1. Basic information 
2. Stroke Rehabilitation Assessment of Movement 
3. Berg Balance Scale 
4. Timed Up & Go Test (if patient can walk) 
5. 6-Minute Walk Test (if patient can walk) 
Second assessment (n = 44)
1. Stroke Rehabilitation Assessment of Movement 
2. Berg Balance Scale 
3. Timed Up & Go Test (if patient can walk) 
4. 6-Minute Walk Test (if patient can walk) 
Third assessment (n = 44)
1. Stroke Rehabilitation Assessment of Movement 
2. Berg Balance Scale 
3. Timed Up & Go Test (if patient can walk) 
4. 6-Minute Walk Test (if patient can walk) 
53 patients meeting the inclusion 
criteria participated and signed 
the consent form
Data analysis 
9 patients dropped out: 
4 refused to continue 
2 moved to another city 
1 had difficulty traveling 
1 became ill 
1 died
Fig. 1. Study protocol.
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(p ¼ 0.014), hemineglect (p ¼ 0.048), and sensory function
(p ¼ 0.009; Table 1).
The seven variables with significant differences were put
into the stepwise discriminant analysis. Only motivation and
functional status prior to stroke were selected. In the pro-
gressive group, the Fisher’s linear discriminant function co-
efficient for functional status prior to stroke was 28.712 and
for motivation was 4.273. The constant was 17.346. The
derived linear discriminant function in the progressive group
was Yprogress, 6m ¼ 17.346 ＋ 28.712  functional status
prior to stroke þ 4.273  motivation. Y indicates the
discriminant value. In the nonprogressive group, the Fisher’s
linear discriminant function coefficient for functional status
prior stroke was 36.129 and for motivation was 6.772. The
constant was 31.480. The derived linear discriminant
function in the nonprogressive group was Ynonprogress,
6m ¼ 31.480 þ 36.129  functional status prior to
stroke þ 6.772  motivation (Table 3). When all observation
values were reclassified and verified by this calculation, 39/
44 patients were predicted correctly. The correct distinction
rate was 88.6 % (Table 4).4. Discussion
We used clinically significant differences to document
factors predicting functional improvement at 3 months and 6
months poststroke. According to our results, motivation,
functional status prior to stroke, history of diabetes, and age
are predictive of motor function improvement 3 months
poststroke. The correct distinction rate was 86.4%. We also
noted that motivation and functional independence prior to
stroke might be predicting factors for motor function
improvement at 6 months poststroke. The correct distinction
rate was 88.6%.
To our knowledge, no other studies have examined the in-
fluence of motivation on functional progress in stroke patients.
In this study, we divided motivation into three levels: “good”,
“ordinary”, and “poor”. We found that more motivated patients
had a higher likelihood of being assigned to the progressive
group.
We found that functional status prior to stroke is an
important predictive factor of functional progress at 3 months
and 6 months poststroke. Of the 44 patients in this study, only
two were disabled prior to stroke and both were assigned to the
Table 1
Demographic information of the participants (n ¼ 44).
Clinical variable Basic information (n ¼ 44) Differences between two
groups 3 mo poststroke
Differences between two
groups 6 mo poststroke
Distribution Range Progressive
group
(n ¼ 35)
Nonprogressive
group (n ¼ 9)
p Progressive
group
(n ¼ 36)
Nonprogressive
group (n ¼ 8)
p
Age (y) 68.7 (13.3) 33e88 66.2 (13.1) 78.6 (9.5) 0.011* 66.4 (12.9) 79.1 (10.1) 0.013*
Interval between stroke onset and initiation
of physical therapy (d)
10.4 (6.2) 2e34 9.8 (5.5) 12.6 (8.4) 0.240 9.8 (5.4) 12.9 (8.9) 0.210
Sex (female/male) 24/20 20/15 4/5 0.710 21/15 3/5 0.436
Stroke type (ischemic/hemorrhagic) 10/34 8/27 2/7 1.00 9/27 1/7 0.659
History of diabetes (yes/no) 18/26 11/24 7/2 0.021* 12/24 6/2 0.048*
History of cardiovascular disease (yes/no) 31/13 22/13 9/0 0.041* 23/13 8/0 0.082
Functional status prior to stroke
(independent/disabled)
42/2 35/0 7/2 0.038* 36/0 6/2 0.030*
Cognitive function (normal/mild
dysfunction/moderate dysfunction/ severe
dysfunction)
28/7/5/4 25/5/2/3 3/2/3/1 0.044* 25/5/3/3 3/2/2/1 0.165
Motivation (good/ordinary/poor) 28/12/4 26/8/1 2/4/3 0.003* 26/9/1 2/3/3 0.004*
Eating ability (independent/dependent) 25/19 24/11 1/8 0.003* 24/12 1/7 0.014*
Walking ability (independent/dependent) 11/33 10/25ssss 1/8 0.411 10/26 1/7 0.656
Hemineglect (normal/hemineglect/
untestable)
30/6/8 26/3/6 4/3/2 0.118 27/3/6 3/3/2 0.048*
Sensory function (normal/impaired) 34/10 30/5 4/5 0.018* 31/5 3/5 0.009*
Brain lesion site (cerebral cortex/subcortical/
multiple)
4/37/3 3/30/2 1/7/1 0.607 3/31/2 1/6/1 0.376
Frequency of physical therapy within 3 mo
of stroke (times)
27.4 (19.6) 3e67 27.7 (18.8) 26 (23.9) 0.815
Frequency of occupational therapy within
3 mo of stroke (times)
25.3 (18.9) 2e63 25.2 (17.9) 25.9 (23.9) 0.921
Frequency of physical therapy within 6 mo
of stroke (times)
44.9 (36.8) 3e133 42.9 (34.5) 54.3 (47.2) 0.436
Frequency of occupational therapy within 6
months of stroke (times)
40.2 (35.3) 2e128 37.1 (32.1) 54.1 (47.3) 0.223
Data are presented as mean (standard deviation) or frequency.
* p < 0.05.
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stroke may affect potential for progress after stroke. However,
additional studies would be necessary to confirm this
proposition.
Our findings with regard to age are not consistent with
those of previous studies. Many studies have concluded that
age is not an important factor in functional progress following
stroke.1,2,5e8 It has been suggested that age is not related to
functional progress when confounding factors are controlled,
even though older patients tend to receive lower scores on the
FIM. In our study the nonprogressive group was significantly
older than the progressive group. In other words, older patients
were more likely to be assigned to the nonprogressive group 3
months poststroke. The difference between our results and
those of others may be related to differing definitions of
functional improvement. However, we also found that age was
no longer an important predictive factor for functional
improvement at 6 months poststroke. The influence of history
of diabetes was similar to that of age.
Using stepwise discriminant analysis, we found that
walking ability, eating ability, and sensory function were not
important predictors of functional progress. Liaw et al8 found
that eating ability and walking ability were predictive ofimprovement in the FIM score at 3 months poststroke. Lin
et al7 suggest that sensory impairment is an important pre-
dictor of functional progress in stroke patients during their
hospitalization. In that study, FIM was the only outcome
measurement, whereas in our study we used STREAM, BBS,
TUG, and 6MWT to measure all aspects of motor function that
are of concern to physical therapists, and we used clinical
significance as an indicator of progress. When predicting
functional improvement in stroke patients, the above-
mentioned studies are useful if the goal is to predict prog-
ress in daily living function, whereas our study is useful if the
goal is to predict clinically significant progress in motor
function in the first 6 months poststroke.
We expected that frequency of physical or occupational
therapy would be predictive of functional progress; however,
we found no significant differences between the progressive
and nonprogressive groups in this measure. Patients in the
nonprogressive group received as many treatments as patients
in the progressive group. However, in this study, the treatment
programs and durations of physical and occupational therapy
were not controlled. Therefore, only the frequency of physical
therapy and occupational therapy may not be able to predict
the functional improvement.
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stroke scale is a good indicator of stroke outcome,25e27 but
whether it is also a good predictor of motor function
improvement is still unclear. The severity of stroke patients in
our study was not explored. It is better to include acute stroke
severity scale, the National Institutes of Health stroke scale,
for analysis in future studies.
We used stepwise discriminant analysis to identify vari-
ables with discriminant ability, and to establish the predictive
potential of the discriminant variables for improvement of
motor function at 3 months and 6 months poststroke. The
discriminant value can be calculated manually. When a patient
is first seen in the rehabilitation department, his or her scores
on the predicting factor measures can be put into the linear
discriminant function formula to calculate the discriminant
value of each group (Yprogress and Ynonprogress). If
Yprogress > Ynonprogress, the prediction is that the patient will
exhibit clinically significant improvement in at least one of the
four measures. Using this metric we achieved an impressive
correct distinction rate (86.4% and 88.6% for 3 months and 6
months poststroke, respectively), indicating that the potential
for motor function improvement at 3 months poststroke can be
predicted based on age, history of diabetes, functional status
prior to stroke, and motivation, and the potential for motor
function improvement at 6 months poststroke can be predicted
by functional status prior to stroke and motivation. We used
the coefficients of a standardized typical discriminant function
to weigh the influence of the variables. Our results indicate
that the most influential variable at 3 months poststroke is
functional status prior to stroke (0.620), followed by history of
diabetes (0.519), motivation (0.508), and age (0.477; Table 2).
At 6 months poststroke, the most influential variable is moti-
vation (0.744), followed by functional status prior to stroke
(0.710; Table 2). Among these predictive factors, motivation is
the only one that can be enhanced; hence, it is imperative to
develop strategies to improve patient motivation poststroke.4.1. Limitations of the studyDue to the limited number of participants in the study,
we were not able to analyze further the four outcome
measurements individually. Therefore, we were able to
predict only the likelihood of improvement in at least one
of the four outcome measurements at 3 months and 6
months poststroke, and not the likelihood of improvement in
the outcome measurements individually. Furthermore,
because the heterogeneity of stroke disease and our partic-
ipants were only selected from a university hospital, and the
types of stroke in this study are uneven (10 ischemic stroke,
34 hemorrhagic stroke), it is possible that our results may
not be generalizable to all stroke patients. The small
enrollment patient number and the largely different patient
number between progressive and nonprogressive groups are
the weaknesses of our study. It is likely that the test items
for the three visits are too sophisticated to recruit patients.
Finally, the lack of stroke severity at admission for analysis
should be noted. Future study should address the above-
Table 3
Discriminant function coefficients for 3 months and 6 months poststroke.
Variable Typical discriminant function coefficients Fisher’s linear discriminant function coefficients
Standardized coefficients Progressive group Nonprogressive group
3 mo poststroke Age 0.477 0.483 0.576
History of diabetes
(yes: 1; no: 0)
0.519 4.884 7.595
Functional status prior to stroke
(independent: 1; disabled: 2)
0.620 32.065 39.904
Motivation
(good: 1; ordinary: 2; poor: 3)
0.508 2.698 4.837
Constant e34.740 e56.661
6 mo poststroke Functional status prior to stroke
(independent: 1; disabled: 2)
0.710 28.712 36.129
Motivation (good: 1; ordinary: 2; poor: 3) 0.744 4.273 6.772
Constant e17.346 e31.480
Table 4
Results analysis for 3 months and 6 months poststroke.
Group Predicted group assignment Total Correct distinction rate
Nonprogressive group Progressive group
3 mo poststroke Actual group Nonprogressive group 6 (66.7) 3 (33.3) 9 (100) 86.4% ¼ (6 þ 32)/44
Progressive group 3 (8.6) 32 (91.4) 35 (100)
6 mo poststroke Actual group Nonprogressive group 4 (50) 4 (50) 8 (100) 88.6% ¼ (4 þ 35)/44
Progressive group 1 (2.8)s 35 (97.2) 36 (100)
Data are presented as n (%) unless otherwise indicated.
475Y.-H. Wang et al. / Journal of the Chinese Medical Association 77 (2014) 469e476mentioned limitations for further validation and clinical
applications.
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